Enno recently joined Jefferies for a fireside chat on Formycon’s strategy, pipeline and commercial outlook.

He discussed Formycon’s transition toward a sustainably profitable commercial biosimilars company, progress across its portfolio, current market dynamics and key milestones ahead.

Thank you to Jefferies for hosting this engaging discussion.

Watch the full recording here: [Link]